Drug Type Antibody drug conjugate (ADC) |
Synonyms DEC 008, DEC008, mMUC16-CPT113 |
Target |
Mechanism MUC16 inhibitors(Mucin-16 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | US | 01 Jan 2025 | |
Neoplasms | Preclinical | US | 19 Dec 2024 | |
Neoplasms | Preclinical | CN | 19 Dec 2024 | |
Neoplasms | Preclinical | CN | 19 Dec 2024 |